BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 18, 2025
See today's BioWorld
Home
» Other news to note for April 6, 2022
To read the full article
sign up for free
or
sign in
.
Other news to note for April 6, 2022
April 6, 2022
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3CL, Abbvie, Addex, Agenus, Aligos, Alloy, Alvotech, Atara, Atreca, AVM, Awakn, Axantia, Betterlife, Biotech Acquisition, Cellpoint, Dragon Overseas, Golden Mountain, HDT, Intas, Isto, Stada, Neurona, Novartis, Neuro-Bio, Novo Nordisk, Oncotelic, Oragenics, Pregene, Regeneron, SQZ, Synaptogenix, Swanbio, Tegmine, Theracell, Todos, Treadwell, Vigeneron, Zymeworks.
BioWorld
Briefs
Other news to note
Coronavirus